Perioperative high-dose selenium supplementation in open thoracic aortic surgery: a post hoc subgroup analysis of the SUSTAIN CSX trial
Abstract
Background: Open surgery on the thoracic aorta is associated with a variable and often pronounced postoperative inflammatory response, which contributes to organ injury and prolonged intensive care unit (ICU) stays. Various anti-inflammatory strategies have been proposed as a way to modulate this response and therefore improve clinical outcomes. The SUSTAIN-CSX randomized controlled trial investigated the effect of perioperative high-dose selenium supplementation on mortality and organ dysfunction in cardiac surgery patients. In this post hoc analysis, we examined its effect on 30-day mortality and organ dysfunction in patients undergoing open thoracic aortic surgery.
Methods: We conducted a post hoc analysis of patients who underwent open thoracic aortic surgery within the SUSTAIN-CSX trial, a multicenter randomized controlled trial evaluating perioperative intravenous high-dose selenium supplementation in cardiac surgery. The selenium regimen consisted of 2,000 µg sodium selenite at anesthesia induction, 2,000 µg immediately postoperatively, and 1,000 µg daily for up to 10 days in the ICU. Patients treated with endovascular interventions of the thoracic aorta were excluded.
Results: A total of 287 patients were included, with 144 randomized to selenium and 143 to placebo. The primary outcome, 30-day mortality, did not differ significantly between groups (selenium 2.8% vs. placebo 3.5%; P=0.73). Clinically relevant postoperative atrial fibrillation (POAF) occurred more…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 287 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.